Lexeo Therapeutics Inc.
LXEO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$257.76M
Close$
$1.03
66.4% downside
Current Fair Value
66.4% downsideOvervalued by 66.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $257.76 Million |
|---|---|
| Enterprise Value | $171.73 Million |
| Earnings per Share | $-1.86 |
| Beta | 1.64 |
| Outstanding Shares | 85,626,751 |
Return
| Return on Equity | -37.12% |
|---|---|
| Return on Assets | -34.24% |
| Return on Invested Capital | 12.85% |
Valuation & Multiples
| P/E Ratio | -2.73 |
|---|---|
| PEG | 302 |
| Price to Sales | - |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 5.59 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.29
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 14, 2026
EPS Estimate
$-0.32
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 315.85% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 103.25% |
|---|---|
| Total Invested | $28,264▼ 99.99% |
| Investors Holding | 1▼ 145.00% |